Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 56, Issue 4, 2007, Pages 1234-1241

  Kozyrev, Sergey V ^a   Lewén, Susanna ^a   Reddy, Prasad M V Linga ^a   Pons Estel, Bernardo ^b   Witte, Torsten ^c   Junker, Peter ^d   Laustrup, Helle ^d   Gutiérrez, Carmen ^e   Suárez, Ana ^e   González Escribano, Maria Francisca ^f   Martín, Javier ^g   Alarcón Riquelme, Marta E ^a   Scherbarth, Hugo R ^h   Marino, Pilar C ^h   Motta, Estela L ^h   Gamron, Susana ⁱ   Drenkard, Cristina ⁱ   Menso, Emilia ⁱ   Allievi, Alberto ^j   Tate, Guillermo A ^j   Presas, Jose L ^k   Palatnik, Simon A ^l   Abdala, Marcelo ^l   Bearzotti, Mariela ^l   Alvarellos, Alejandro ^m   Caeiro, Francisco ^m   Bertoli, Ana ^m   Paira, Sergio ⁿ   Roverano, Susana ⁿ   Graf, Cesar E ^o   Bertero, Estela ^o   Caprarulo, Cesar ^p   Buchanan, Griselda ^p   Guillerón, Carolina ^q   Grimaudo, Sebastian ^q   Manni, Jorge ^q   Catoggio, Luis J ^r   Soriano, Enrique R ^r   Santos, Carlos D ^r   Prigione, Cristina ^s   Ramos, Fernando A ^s   Navarro, Sandra M ^s   Berbotto, Guillermo A ^t   Jorfen, Marisa ^t   Romero, Elisa J ^t   Garcia, Mercedes A ^u   Marcos, Juan C ^u   Marcos, Ana I ^u   Perandones, Carlos E ^v   Eimon, Alicia ^v   Battagliotti, Cristina G ^w   Armadi Simab, K ^x   Gross, Wolfgang L ^x   Gromnica IhIe, Erika ^y   Peter, Hans Hartmut ^z   Manger, Karin ^aa   Schnarr, Sebastian ^c   Zeidler, Henning ^c   Schmidt, Reinhold E ^ab   Ortego, Norberto ^ac   De Ramón, Enrique ^ad   Jiménez Alonso, Juan ^ae   Sánchez Román, Julio ^f   López Nevot, Miguel Ángel ^ae   more..

^a UPPSALA UNIVERSITY   (Sweden)

^b Sanatorio Parque   (Argentina)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^h Hosp Interzonal General de Agudos   (Argentina)

ⁱ UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^j Organización Médica de Investigaciones OMI   (Argentina)

^k HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^l UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^m HOSPITAL PRIVADO   (Argentina)

ⁿ Hospital Jose M Cullen   (Argentina)

^o HOSPITAL SAN MARTÍN   (Argentina)

^p Hospital Felipe Heras   (Argentina)

^q INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^r HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^s Hospital Provincial de Rosario   (Argentina)

^t Hospital Eva Peron   (Argentina)

^u Hospital Interzonal General de Agudos de La Plata   (Argentina)

^v CEMIC   (Argentina)

^w 'O Alassia' Children's Hospital   (Argentina)

^x UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^y Rheumaklinik Berlin Buch   (Germany)

^z UNIVERSITY OF FREIBURG   (Germany)

^aa UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^ab UNIVERSITY OF APPLIED SCIENCES AND ARTS   (Germany)

^ac HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^ad HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^ae HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 5; ISOPROTEIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; EXON; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENETIC RISK; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ASSAY; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; FAMILY HEALTH; FEMALE; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTORS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; NUCLEAR FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RISK FACTORS; RNA SPLICING; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 34247254495     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22497     Document Type: Article

References (16)

1. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001;19:623-55.
2. Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, et al. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms: multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 2005;280:21078-90.
3. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005;76:528-37.
4. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006;38:550-5.
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. Jacobs GH, Stockwell PA, Tate WP, Brown CM. Transterm - extended search facilities and improved integration with other databases. Nucleic Acids Res 2006;34:D37-40.
7. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype - phenotype associations. Eur J Hum Genet 2001;9:301-6.
8. Wang G, Guo X, Floras J. Differences in the translation efficiency and mRNA stability mediated by 5′-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 2005;289:L497-508.
9. Gray NK, Wickens M. Control of translation initiation in animals. Annu Rev Cell Dev Biol 1998;14:399-458.
10. Clark AR, Dean JL, Saklatvala J. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett 2003;546:37-44.
11. Khabar KS. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J Interferon Cytokine Res 2005;25:1-10.
12. Jacob CO, Lee SK, Strassmann G. Mutational analysis of TNF-α gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol 1996;156:3043-50.
13. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999;10:387-98.
14. Randall RA, Germain S, Inman GJ, Bates PA, Hill CS. Different Smad partners bind a common hydrophobic pocket in Smad2 via defined proline-rich motif. EMBO J 2002;21:145-56.
15. Swingler TE, Bess KL, Yao J, Stifani S, Jayaraman PS. The proline-rich homeodomain protein recruits members of the Groucho/Transducin-like enhancer of split protein family to co-repress transcription in hematopoietic cells. J Biol Chem 2004;279:34938-47.
16. Prado F, Vincent G, Cardalda C, Beato M. Differential role of the proline-rich domain of nuclear factor 1-C splice variants in DNA binding and transactivation. J Biol Chem 2002;277:16383-90.